Table II.
Treatment details for patients receiving any first-line treatment, n = 2097.
| Treatment | n (%)* |
|---|---|
| Full chemotherapy regimen | 699 |
| Full ABVD/AVD | 635 (90.8) |
| Full BEACOPP | † |
| Full CHOP | † |
| Full COPP | 27 (3.9) |
| Full MOPP | † |
| Full PVAG | † |
| Full Stanford V | 22 (3.1) |
| Full VEPEMB | † |
| Partial chemotherapy regimen | 1016 |
| Partial chemotherapy regimen | 1016 (100) |
| Single chemotherapy agent or RT | 382 |
| Single chemotherapy agent only | 147 (38.5) |
| RT only | >244 (>58.6)† |
| Both | † |
*
Denominator for specific treatment is the number in the overall treatment category.
†
Cell counts < 11 were suppressed and other cells were coarsened to avoid re-identification of patients in accordance with SEER-Medicare policy.